Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARDTNASDAQ:GHNYSE:HIMSNASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARDTArdent Health Partners$11.98-5.5%$13.99$11.60▼$20.72$1.71BN/A457,342 shs42,402 shsGHGuardant Health$40.05-8.7%$43.77$15.81▼$50.89$4.96B1.452.13 million shs601,390 shsHIMSHims & Hers Health$26.48-10.2%$39.29$11.20▼$72.98$5.88B1.6522.93 million shs8.43 million shsOPCHOption Care Health$33.09-1.4%$33.17$21.39▼$35.53$5.44B1.071.75 million shs410,795 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARDTArdent Health Partners+6.30%-1.48%-9.73%-22.91%+1,264,999,900.00%GHGuardant Health+10.20%+0.87%+22.41%+19.90%+128.49%HIMSHims & Hers Health+12.95%-5.67%-14.40%+14.19%+102.01%OPCHOption Care Health+2.35%-3.54%+0.54%+39.02%+4.97%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARDTArdent Health PartnersN/AN/AN/AN/AN/AN/AN/AN/AGHGuardant Health4.2607 of 5 stars3.52.00.04.34.12.50.6HIMSHims & Hers Health3.6293 of 5 stars4.12.00.00.02.23.31.9OPCHOption Care Health3.8966 of 5 stars2.43.00.04.24.32.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARDTArdent Health Partners 3.00Buy$20.5870.48% UpsideGHGuardant Health 3.00Buy$49.2421.55% UpsideHIMSHims & Hers Health 2.21Hold$38.2540.51% UpsideOPCHOption Care Health 2.75Moderate Buy$33.00-1.12% DownsideCurrent Analyst Ratings BreakdownLatest ARDT, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/10/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$60.00 ➝ $55.004/10/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$55.004/10/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$39.00 ➝ $33.004/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$16.004/9/2025ARDTArdent Health PartnersMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$19.00 ➝ $18.004/2/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell4/1/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.003/26/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.003/26/2025GHGuardant HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$55.00 ➝ $55.003/18/2025HIMSHims & Hers HealthBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderperform ➝ Underperform$21.00 ➝ $22.003/6/2025GHGuardant HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$42.00 ➝ $52.00(Data available from 4/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARDTArdent Health Partners$5.97B0.29N/AN/AN/A∞GHGuardant Health$739.02M6.77N/AN/A$1.34 per share30.23HIMSHims & Hers Health$1.48B4.10N/AN/A$1.61 per share16.91OPCHOption Care Health$5.00B1.10$1.94 per share17.19$8.03 per share4.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARDTArdent Health Partners$53.90MN/A0.006.16N/AN/AN/AN/A5/28/2025 (Estimated)GHGuardant Health-$479.45M-$3.56N/AN/AN/A-59.05%-19,157.20%-25.96%5/8/2025 (Estimated)HIMSHims & Hers Health-$23.55M$0.5461.7252.35N/A8.19%10.97%8.29%5/5/2025 (Estimated)OPCHOption Care Health$267.09M$1.2227.9526.492.304.37%15.30%6.57%4/29/2025 (Estimated)Latest ARDT, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025GHGuardant Health-$0.57N/AN/AN/A$189.91 millionN/A5/5/2025Q1 2025HIMSHims & Hers Health$0.11N/AN/AN/A$535.21 millionN/A4/29/2025Q1 2025OPCHOption Care Health$0.36N/AN/AN/A$1.26 billionN/A2/26/2025Q4 2024ARDTArdent Health Partners$0.50$0.81+$0.31$0.81$1.48 billion$1.61 billion2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARDTArdent Health PartnersN/AN/AN/AN/AN/AGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARDTArdent Health Partners0.781.911.78GHGuardant HealthN/A6.225.85HIMSHims & Hers HealthN/A2.141.82OPCHOption Care Health0.771.731.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARDTArdent Health PartnersN/AGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipARDTArdent Health PartnersN/AGHGuardant Health5.50%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARDTArdent Health Partners24,200142.75 millionN/AOptionableGHGuardant Health1,790123.42 million116.76 millionNot OptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableOPCHOption Care Health5,600164.24 million169.09 millionOptionableARDT, HIMS, OPCH, and GH HeadlinesRecent News About These Companies4 Stocks to Watch in a Dynamic Outpatient Home Health IndustryApril 10 at 2:35 AM | zacks.com4 Stocks to Watch in a Dynamic Outpatient Home Health IndustryApril 10 at 2:35 AM | zacks.comBest Growth Stocks to Buy for April 9thApril 9 at 10:01 AM | zacks.comBest Growth Stocks to Buy for April 9thApril 9 at 10:01 AM | zacks.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Bought by JPMorgan Chase & Co.April 9 at 3:34 AM | marketbeat.com90,500 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Prospector Partners LLCApril 8 at 6:59 AM | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Stake Raised by Landscape Capital Management L.L.C.April 8 at 5:06 AM | marketbeat.comMassachusetts Financial Services Co. MA Sells 100,825 Shares of Option Care Health, Inc. (NASDAQ:OPCH)April 7 at 4:31 AM | marketbeat.comHeadlands Technologies LLC Makes New $359,000 Investment in Option Care Health, Inc. (NASDAQ:OPCH)April 6, 2025 | marketbeat.comBrokerages Set Option Care Health, Inc. (NASDAQ:OPCH) Target Price at $33.00April 6, 2025 | americanbankingnews.comNorges Bank Acquires New Shares in Option Care Health, Inc. (NASDAQ:OPCH)April 5, 2025 | marketbeat.comTrexquant Investment LP Purchases Shares of 437,971 Option Care Health, Inc. (NASDAQ:OPCH)April 4, 2025 | marketbeat.comBlair William & Co. IL Reduces Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)April 4, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Given Average Recommendation of "Moderate Buy" by BrokeragesApril 4, 2025 | marketbeat.comWilliam Blair Sticks to Their Buy Rating for Option Care Health (OPCH)April 3, 2025 | markets.businessinsider.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Schroder Investment Management GroupApril 3, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by Vanguard Group Inc.April 3, 2025 | marketbeat.comSei Investments Co. Sells 74,969 Shares of Option Care Health, Inc. (NASDAQ:OPCH)April 3, 2025 | marketbeat.comBest Growth Stocks to Buy for April 3rdApril 3, 2025 | zacks.comShould You Think About Buying Option Care Health, Inc. (NASDAQ:OPCH) Now?April 2, 2025 | uk.finance.yahoo.comAxiom Investors LLC DE Grows Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)April 2, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a BuyBy Thomas Hughes | March 12, 2025View NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy4 Healthcare Stocks With Massive Gains—and More to ComeBy Sarah Horvath | March 29, 2025View 4 Healthcare Stocks With Massive Gains—and More to Come2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead RatingBy Gabriel Osorio-Mazilli | April 1, 2025View 2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead RatingHims’ Weight Loss Expansion: Real Growth or Just Hype?By Leo Miller | April 10, 2025View Hims’ Weight Loss Expansion: Real Growth or Just Hype?ARDT, HIMS, OPCH, and GH Company DescriptionsArdent Health Partners NYSE:ARDT$11.98 -0.69 (-5.45%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Guardant Health NASDAQ:GH$40.12 -3.75 (-8.54%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$26.48 -3.01 (-10.21%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$33.08 -0.48 (-1.44%) As of 12:20 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom's Big Outperformance Shows Strength Amid Tariff Decline Delta, Walmart Cut Profit Targets: Could Start Domino Effect Joby Aviation: Operational Momentum vs. Market Sentiment Carvana: Can Turnaround Strength Outdrive Market Headwinds? Is Alphabet a Generational Buying Opportunity at These Levels? Meta Seeks Trump's Help in FTC Trial: The Implications Are Huge Is Microsoft Stock Too Cheap to Ignore After Its Latest Drop? Harley-Davidson Tops Watchlists: Value Trap or Turnaround Play? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
